Rising Stars: Medical Aesthetics Set for Bright Growth to 2025

The burgeoning field of medical aesthetics presents an exciting opportunity, with forecasted Compound Annual Growth Rates CAGR reaching as high as 11.9 for neuromodulator treatments such as Botox in the United States and Canada by 2025. The market for dermal fillers using injectables like hyaluronic acid and biostimulators, on the other hand, is expected to grow at a steady CAGR of approximately 3.8 over the same period.

Let's delve deeper into these figures with a visual representation:

Stacked Bar Graph

A pr of stacked bar graphs illustrating the annual number and market size of neuromodulator and dermal-filler injectable procedures in Canada and the United States from 2019 to 2023, projected through to 2025.

• The first graph outlines the sheer volume of these procedures: starting at 11.7 million procedures in 2019, this number soared to an impressive 19.9 million by 2023, with expectations peaking at around 23.0 million procedures anticipated in 2025.

• The second graph focuses on the monetary value of these treatments: with a market size starting at $2.7 billion in 2019, it expanded to $4.4 billion by 2023, and is forecasted to grow further to approximately $5.2 billion by 2025.

To explore this topic further, you can read the full article titled Here to Stay: An Attractive Future for Medical Aesthetics, published on February 1, 2024.

For those interested in subscribing to receive our latest charts strght to your inbox each Saturday, simply sign up for The Week in Charts newsletter below.
This article is reproduced from: https://www.mckinsey.com/featured-insights/sustainable-inclusive-growth/chart-of-the-day/growth-market-for-medical-aesthetics

Please indicate when reprinting from: https://www.014r.com/Plastic_surgery_and_cosmetic_images/Medical_Aesthetics_Growth_2019_2025.html